Patent Assignment
Reel/Frame 064251/0794
Assignment of Assignor's Interest
Recorded: 2023-07-11
Pages: 63
Assignor
CODIAK BIOSCIENCES, INC.
Executed: 2023-06-15
Assignee
LONZA SALES AG
MÜNCHENSTEINERSTRASSE 38, BASEL, 4052, SWITZERLAND
Covered Properties
(205)
Methods of Suppressing Delivery of Exosomes to Liver, Lung and Spleen
Application:
62/378,122 →
Methods of Suppressing Delivery of Exosomes to Liver and Spleen
Application:
16/327,282 →
Publication:
US 2021/0290556
Methods of Measuring Exosomes Using Intrinsic Fluorescence
Application:
62/434,985 →
Methods of Measuring Exosomes Using Intrinsic Fluorescence
Application:
62/542,697 →
Methods of Measuring Exosomes Using Intrinsic Fluorescence
Application:
16/470,180 →
Publication:
US 2020/0025685
Methods of Measuring Exosomes Using Intrinsic Fluorescence
Nanovesicles Produced from Mesenchymal Stromal Cells for Anti-Inflammatory Applications
Application:
62/533,629 →
Nanovesicles Produced from Mesenchymal Stromal Cells for Anti-Inflammatory Applications
Application:
16/632,122 →
Publication:
US 2020/0163998
Preparation of Therapeutic Exosomes Using Membrane Proteins
Application:
62/550,543 →
Preparation of Therapeutic Exosomes Using Membrane Proteins
Application:
62/656,956 →
Preparation of Therapeutic Exosomes Using Membrane Proteins
Preparation of Therapeutic Exosomes Using Membrane Proteins
Preparation of Therapeutic Exosomes Using Membrane Proteins
Preparation of Therapeutic Exosomes Using Membrane Proteins
Production of Extracellular Vesicles in Single-Cell Suspension Using Chemically-Defined Cell Culture Media
Application:
62/561,206 →
Production of Extracellular Vesicles in Single-Cell Suspension Using Chemically-Defined Cell Culture Media
Application:
62/668,217 →
Production of Extracellular Vesicles in Single-Cell Suspension using Chemically-Defined Cell Culture Media
Application:
16/137,176 →
Publication:
US 2019/0085284
Production of Extracellular Vesicles in Single-Cell Suspension Using Chemically-Defined Cell Culture Media
Application:
18/172,176 →
Publication:
US 2024/0002785
Loading of Extracellular Vesicles Through Imparting of Mechanical Shear
Application:
62/588,143 →
Loading of Extracellular Vesicles through Imparting of Mechanical Shear
Application:
16/190,058 →
Publication:
US 2019/0175506
Loading of Extracellular Vesicles Through Imparting of Mechanical Shear
Application:
17/014,961 →
Publication:
US 2021/0093568
Loading of Extracellular Vesicles Through Imparting of Mechanical Shear
Compositions of Engineered Exosomes and Methods of Loading Lumenal Exosome Payloads
Application:
62/587,767 →
Compositions of Engineered Exosomes and Methods of Loading Luminal Exosome Payloads
Application:
62/634,750 →
Compositions of Engineered Exosomes and Methods of Loading Luminal Exosomes Pay-Loads
Application:
16/765,116 →
Publication:
US 2020/0347112
Compositions of Engineered Exosomes and Methods of Loading Luminal Exosome Payloads
Application:
16/194,230 →
Publication:
US 2019/0151456
Compositions of Engineered Exosomes and Methods of Loading Luminal Exosomes Pay-Loads
Application:
18/057,709 →
Publication:
US 2024/0000944
Exosomes for Immuno-Oncology and Anti-Inflammatory Therapy
Application:
62/611,140 →
Exosomes for Immuno-Oncology and Anti-Inflammatory Therapy
Application:
62/723,267 →
Exosomes for Immuno-Oncology and Anti-Inflammatory Therapy
Exosomes for Immuno-Oncology and Anti-Inflammatory Therapy
Exosomes for Immuno-Oncology and Anti-Inflammatory Therapy
Methods and Compositions for Macrophage Polarization
Application:
62/629,563 →
Methods and Compositions for Macrophage Polarization
Methods and Compositions for Macrophage Polarization
Exosome Encapsulated Sting-Agonists
Application:
62/647,491 →
Exosome Encapsulated Sting-Agonists
Application:
62/680,501 →
Exosome Encapsulated Sting-Agonists
Application:
62/688,600 →
Exosome Encapsulated Sting-Agonists
Application:
62/756,247 →
Extracellular Vesicles Comprising Sting-Agonist
Application:
62/822,019 →
Extracellular Vesicles Comprising Sting-Agonist
Application:
17/040,805 →
Publication:
US 2021/0322327
Methods of Measuring Extracellular Vesicles and Nanoparticles in Complex Matrices by Light Scattering
Application:
62/688,304 →
Methods of Measuring Extracellular Vesicles and Nanoparticles in Complex Matrices by Light Scattering
Methods to Improve Potency of Electroporation
Application:
62/750,121 →
Methods to Improve Potency of Electroporation
Application:
17/288,719 →
Publication:
US 2021/0395721
Treatment of Cancer Metastasis by Targeting Exosome Proteins
Application:
62/800,930 →
Treatment of Cancer Metastasis by Targeting Exosome Proteins
Membrane Protein Scaffolds for Exosome Engineering
Application:
62/801,065 →
Membrane Protein Scaffolds for Exosome Engineering
Application:
62/801,636 →
Membrane Protein Scaffolds for Exosome Engineering
Application:
62/851,581 →
Membrane Protein Scaffolds for Exosome Engineering
Application:
17/428,245 →
Publication:
US 2022/0249373
Exosome for Vaccine Delivery
Application:
62/822,008 →
Extracellular Vesicles for Vaccine Delivery
Application:
62/835,437 →
Extracellular Vesicles for Vaccine Delivery
Application:
62/840,348 →
Extracellular Vesicles for Vaccine Delivery
Application:
62/891,048 →
Extracellular Vesicles for Vaccine Delivery
Application:
62/901,166 →
Extracellular Vesicles for Vaccine Delivery
Application:
62/946,280 →
Extracellular Vesicles for Vaccine Delivery
Application:
62/984,146 →
Extracellular Vesicles for Vaccine Delivery
Extracellular Vesicles for Vaccine Delivery
Process for Preparing Extracellular Vesicles
Application:
62/822,013 →
Process for Preparing Extracellular Vesicles
Application:
62/835,436 →
Process for Preparing Extracellular Vesicles
Application:
62/903,524 →
Process for Preparing Extracellular Vesicles
Application:
62/946,895 →
Process for Preparing Extracellular Vesicles
Application:
62/984,141 →
Process for Preparing Extracellular Vesicles
Process for Preparing Extracellular Vesicles
Application:
18/050,011 →
Publication:
US 2024/0066433
Extracellular Vesicle Conjugates and Uses Thereof
Application:
62/822,014 →
Extracellular Vesicle Conjugates and Uses Thereof
Application:
62/835,439 →
Extracellular Vesicle Conjugates and Uses Thereof
Application:
17/441,162 →
Publication:
US 2024/0108747
Engineered Exracellular Vesicles and Uses Thereof
Application:
62/835,430 →
Engineered Extracellular Vesicles and Uses Thereof
Application:
17/293,833 →
Publication:
US 2022/0017907
Engineered Extracellular Vesicles and Uses Thereof
Application:
62/835,427 →
Methods for Treating Tuberculosis
Application:
62/840,330 →
Engineered Extracellular Vesicles and Uses Thereof
Application:
62/851,567 →
Methods of Treating Tuberculosis
Application:
17/594,401 →
Publication:
US 2022/0218811
Extracellular Vesicles Targeting Dendritic Cells and Uses Thereof
Application:
62/891,092 →
Extracellular Vesicles Targeting Dendritic Cells and Uses Thereof
Application:
62/903,495 →
Methods of Inducing Hematopoiesis
Application:
62/870,483 →
Extracellular Vesicle Linked to Molecules and Uses Thereof
Application:
62/886,941 →
Extracellular Vesicle Linked to Molecules and Uses Thereof
Application:
62/895,398 →
Extracellular Vesicle Linked to Molecules and Uses Thereof
Application:
17/634,897 →
Publication:
US 2022/0354963
Extracellular Vesicle-Aso Constructs Targeting Cebp/Beta
Application:
62/886,930 →
Extracellular Vesicle-Aso Constructs Targeting Cebp/Beta
Application:
62/900,136 →
Extracellular Vesicle-Aso Constructs Targeting Cebp/Beta
Application:
62/936,220 →
Extracellular Vesicle-Aso Constructs Targeting Cebp/Beta
Application:
62/944,204 →
Extracellular Vesicle-Aso Constructs Targeting Cebp/Beta
Application:
62/989,540 →
Extracellular Vesicle-Aso Constructs Targeting Cebp/Beta
Application:
63/023,065 →
Extracellular Vesicle-Aso Constructs Targeting Cebp/Beta
Application:
63/035,357 →
Extracellular Vesicle-Aso Constructs Targeting Cebp/Beta
Application:
17/635,284 →
Publication:
US 2023/0002764
Extracellular Vesicles with STAT3/Nras Antisense Oligonucleotides
Application:
62/886,901 →
Extracellular Vesicles with STAT3/Nras Antisense Oligonucleotides
Application:
62/900,371 →
Extracellular Vesicles with STAT3-Antisense Oligonucleotides
Application:
17/635,315 →
Publication:
US 2023/0193274
Extracellular Vesicles with Antisense Oligonucleotides
Application:
62/886,904 →
Extracellular Vesicles with Antisense Oligonucleotides
Application:
62/900,376 →
Extracellular Vesicles with Antisense Oligonucleotides Targeting Kras
Application:
62/886,885 →
Extracellular Vesicles with Antisense Oligonucleotides Targeting Kras
Application:
17/635,298 →
Publication:
US 2023/0018254
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
62/886,944 →
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
62/900,138 →
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
62/903,518 →
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
62/936,216 →
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
62/989,477 →
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
63/035,392 →
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
17/635,322 →
Publication:
US 2025/0115904
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
18/050,017 →
Publication:
US 2024/0254481
Extracellular Vesicles Targeting Dendritic Cells and Uses Thereof
Application:
62/870,574 →
Extracellular Vesicles Targeting Dendritic Cells and Uses Thereof
Application:
17/271,176 →
Publication:
US 2023/0181758
Methods of Producing Extracellular Vesicles
Application:
62/906,023 →
Methods of Producing Extracellular Vesicles
Application:
63/059,754 →
Methods of Producing Extracellular Vesicles
Application:
63/066,654 →
Methods of Producing Extracellular Vesicles
Application:
17/754,174 →
Publication:
US 2023/0103726
Extracellular Vesicle Compositions
Application:
62/906,018 →
Extracellular Vesicle Compositions
Application:
62/906,485 →
Extracellular Vesicle Compositions
Application:
17/763,996 →
Publication:
US 2024/0099973
Combination Therapy Using Extracellular Vesicles
Application:
62/906,016 →
Combination Therapy Using Extracellular Vesicles
Application:
63/066,605 →
Combination Therapy Using Extracellular Vesicles
Application:
63/070,149 →
Sting Agonist Comprising Exosomes Combined with Il-12 Displaying Exosomes for Treating a Tumour
Application:
17/763,973 →
Publication:
US 2022/0395465
Method of Treating Neuroimmunological Disorders
Application:
62/906,002 →
Method of Treating Neuroimmunological Disorders
Application:
62/989,528 →
Method of Treating Neuroimmunological Disorders
Application:
62/704,986 →
Sting Agonist Comprising Exosomes for Treating Neuroimmunological Disorders
Application:
17/754,177 →
Publication:
US 2023/0241089
Exogenous Loading of Exosomes via Lyophilization
Application:
62/905,999 →
High-Throughput Chromatography Screening for Extracellular Vesicles
Application:
62/931,089 →
High-Throughput Chromatography Screening for Extracellular Vesicles
Application:
17/774,774 →
Publication:
US 2022/0390437
Cholesterol Assays for Quantifying Extracellular Vesicles
Application:
62/962,691 →
Cholesterol Assays for Quantifying Extracellular Vesicles
Application:
63/047,159 →
Cholesterol Assays for Quantifying Extracellular Vesicles
Application:
17/793,629 →
Publication:
US 2023/0184791
Extracellular Vesicles Targeting T Cells and Uses Thereof
Application:
62/962,649 →
Extracellular Vesicles Targeting T Cells and Uses Thereof
Application:
63/035,307 →
Extracellular Vesicles Targeting T Cells and Uses Thereof
Application:
17/624,524 →
Publication:
US 2022/0251200
Extracellular Vesicles for Treating Neurological Disorders
Application:
62/989,491 →
Extracellular Vesicles for Treating Neurological Disorders
Application:
63/010,603 →
Extracellular Vesicles for Treating Neurological Disorders
Application:
63/016,213 →
Extracellular Vesicles for Treating Neurological Disorders
Application:
63/035,367 →
Extracellular Vesicles for Treating Neurological Disorders
Application:
63/050,651 →
Extracellular Vesicles for Treating Neurological Disorders
Application:
63/055,657 →
Extracellular Vesicles for Treating Neurological Disorders
Application:
63/059,103 →
Extracellular Vesicles for Treating Neurological Disorders
Application:
17/906,177 →
Publication:
US 2023/0114434
Methods of Targeting Extracellular Vesicles to the Central Nervous System
Application:
62/989,535 →
Methods of Targeting Extracellular Vesicles to the Central Nervous System
Application:
62/704,998 →
Methods of Targeting Extracellular Vesicles to the Central Nervous System
Application:
63/154,563 →
Methods of Treating Neuroinflammation
Application:
62/989,530 →
Methods of Treating Neuroinflammation
Application:
62/704,992 →
Extracellular Vesicle-Aso Constructs Targeting PMP22
Application:
62/989,534 →
Extracellular Vesicle-Aso Constructs Targeting PMP22
Application:
62/704,996 →
Extracellular Vesicles for Coronavirus Therapy
Application:
63/001,088 →
Extracellular Vesicles for Coronavirus Therapy
Application:
63/003,171 →
Extracellular Vesicles for Coronavirus Therapy
Application:
63/006,585 →
Extracellular Vesicles for Coronavirus Therapy
Application:
63/017,514 →
Extracellular Vesicles for Coronavirus Therapy
Application:
63/142,418 →
Extracellular Vesicles for Therapy
Application:
17/906,849 →
Publication:
US 2025/0114445
Anti-Transferrin Extracellular Vesicles
Application:
63/035,370 →
Anti-Transferrin Extracellular Vesicles
Application:
63/161,362 →
Anti-Transferrin Extracellular Vesicles
Application:
18/000,799 →
Publication:
US 2023/0220068
Methods of Targeting Extracellular Vesicles to Lung
Application:
63/028,460 →
Methods of Targeting Extracellular Vesicles to Lung
Application:
62/704,988 →
Methods of Targeting Extracellular Vesicles to Lung
Application:
63/181,883 →
Methods of Treating Cancer
Application:
63/066,603 →
Methods of Treating Cancer
Application:
63/069,423 →
Methods of Treating Cancer
Application:
63/131,870 →
Methods of Treating Cancer
Application:
63/136,051 →
Methods of Treating Cancer
Application:
63/145,762 →
Methods of Treating Cancer
Application:
63/166,772 →
Methods of Treating Cancer
Application:
18/042,068 →
Publication:
US 2025/0249072
Process for Preparing Extracellular Vesicles
Application:
63/082,358 →
Process for Preparing Extracellular Vesicles
Application:
18/246,312 →
Publication:
US 2023/0366794
Process for Preparing Extracellular Vesicles
Application:
63/082,434 →
Process for Preparing Extracellular Vesicles
Application:
63/083,034 →
Process for Preparing Extracellular Vesicles
Application:
18/246,301 →
Publication:
US 2024/0241020
Methods of Producing Extracellular Vesicle-Based Vaccines
Application:
63/082,453 →
Methods of Producing Extracellular Vesicles
Application:
63/161,331 →
Methods of Producing Extracellular Vesicles
Application:
18/246,304 →
Publication:
US 2024/0082389
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
63/088,312 →
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
63/141,829 →
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
63/160,596 →
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
63/169,753 →
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
63/225,852 →
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
63/244,626 →
Extracellular Vesicle-Aso Constructs Targeting STAT6
Application:
18/248,036 →
Publication:
US 2023/0364127
Extracellular Vesicles Comprising Kras Antigens and Uses Thereof
Application:
63/082,433 →
Extracellular Vesicle-NLRP3 Antagonist
Application:
63/150,453 →
Optimized Linkers
Application:
63/150,523 →
Methods of Loading Extracellular Vesicles
Application:
63/150,497 →
Extracellular Vesicle Compositions
Application:
63/169,751 →
Modified Producer Cells for Extracellular Vesicle Production and Methods of Use Thereof
Application:
63/255,857 →
Extracellular Vesicle Comprising Cholesterol Tagged Sting-Agonist
Application:
63/261,918 →
Extracellular Vesicle Comprising Cholesterol Tagged Sting-Agonist
Application:
63/364,875 →
Methods of Administering a Sting Agonist
Application:
63/357,568 →
Extracellular Vesicle Comprising a Biologically Active Molecule and a Cleavable Linker
Application:
63/371,709 →
Methods of Using Extracellular Vesicle-Aso Targeting STAT6
Application:
63/357,573 →
Methods of Using Extracellular Vesicle-Aso Targeting STAT6
Application:
63/385,371 →
Extracellular Vesicle-Aso Constructs Targeting Cebp/Beta
Application:
63/369,650 →
Extracellular Vesicle Comprising a Biologically Active Molecule and a Dual Cleavable Linker
Application:
63/371,707 →
Extracellular Vesicle Comprising a Biologically Active Molecule and a Cell Penetrating Peptide Cleavable Linker
Application:
63/371,711 →
Methods of Treating a Tumor
Application:
63/357,552 →
Use of Monolithic Anion Exchange Chromatography and Light Scattering for Quantifying Extracellular Vesicles
Application:
63/390,266 →
Methods for Producing Extracellular Vesicles
Application:
63/490,750 →
Process for Preparing Extracellular Vesicles
Application:
63/499,032 →
Extracellular Vesicle-NLRP3 Antagonist
PCT:
PCT/US2022/016828 ↗
Optimized Linker
PCT:
PCT/US2022/016870 ↗
Methods of Loading Extracellular Vesicles
PCT:
PCT/US2022/016825 ↗
Extracellular Vesicle Compositions
PCT:
PCT/US2022/023120 ↗
Modified Producer Cells for Extracellular Vesicle Production
PCT:
PCT/US2022/078150 ↗
Extracellular Vesicle Comprising Cholesterol Tagged Sting-Agonist
PCT:
PCT/US2022/077424 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 18, 2017
From: WILLIAMS, DOUG
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 041010/0548 →
Assignment of Assignor's Interest
Feb 2, 2017
From: HOUDE, DAMIAN; WILLIAMS, DOUGLAS E.
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 041162/0268 →
Assignment of Assignor's Interest
Jul 24, 2017
From: PARK, KYUNG-SU; BANDEIRA DE MELO, ELGA BERNARDO; LOTVALL, JAN
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 043082/0340 →
Assignment of Assignor's Interest
Sep 6, 2017
From: WILLIAMS, DOUGLAS E.; CHOI, YOUNG JUN; HOUDE, DAMIAN
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 043499/0792 →
Assignment of Assignor's Interest
Sep 11, 2017
From: DOOLEY, KEVIN; HARRISON, RANE A.; MCCONNELL, RUSSELL E.; XU, KE
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 043543/0546 →
Assignment of Assignor's Interest
Oct 5, 2017
From: VILLIGER, AGATA A.; GRUBE, ANDREW F.; CHAN, TIK YAN; ESTES, SCOTT D.
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 043799/0539 →
Assignment of Assignor's Interest
Nov 27, 2017
From: NOYES, AARON R.; MERCALDI, MICHAEL P.; GOLDEN, KATHRYN E.; BOURDEAU, RAYMOND W.
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 044227/0616 →
Assignment of Assignor's Interest
Nov 29, 2017
From: DOOLEY, KEVIN P.; HARRISON, RANE A.; XU, KE; HOUDE, DAMIAN J.
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 044254/0499 →
Assignment of Assignor's Interest
Mar 1, 2018
From: DOOLEY, KEVIN P.; HARRISON, RANE A.; XU, KE; HOUDE, DAMIAN J.
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 045082/0882 →
Assignment of Assignor's Interest
May 9, 2018
From: LEWIS, NURUDDEEN D.; ZHOU, YU; KULMAN, JOHN D.; SATHYANARAYANAN, SRIRAM
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 045758/0972 →
Assignment of Assignor's Interest
May 14, 2018
From: VILLIGER, AGATA A.; GRUBE, ANDREW F.; CHAN, TIK YAN; ESTES, SCOTT D.
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 045795/0275 →
Assignment of Assignor's Interest
Oct 5, 2018
From: DOOLEY, KEVIN P.; HARRISON, RANE A.; MCCONNELL, RUSSELL E.; XU, KE
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 047202/0503 →
Assignment of Assignor's Interest
Oct 5, 2018
From: VILLIGER, AGATA A.; GRUBE, ANDREW F.; CHAN, TIK YAN; ESTES, SCOTT D.
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 047086/0420 →
Assignment of Assignor's Interest
Oct 5, 2018
From: DOOLEY, KEVIN; HARRISON, RANE A.; MCCONNELL, RUSSELL E.; XU, KE
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 047086/0323 →
Assignment of Assignor's Interest
Dec 11, 2018
From: NOYES, AARON R.; MERCALDI, MICHAEL P.; GOLDEN, KATHRYN E.; KONSTANTINOV, KONSTANTIN
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 047745/0586 →
Corrective Assignment to Correct the 7TH Inventor Name Previously Recorded at Reel: 047745 Frame: 0586. Assignor(S) Hereby Confirms the Assignment.
Jan 10, 2019
From: NOYES, AARON R.; MERCALDI, MICHAEL P.; GOLDEN, KATHRYN E.; KONSTANTINOV, KONSTANTIN
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 048044/0855 →
Assignment of Assignor's Interest
Nov 21, 2019
From: HOUDE, DAMIAN J; CHOI, YOUNG JUN; KULMAN, JOHN D; WILLIAMS, DOUGLAS E
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 051080/0389 →
Assignment of Assignor's Interest
Nov 22, 2019
From: DOOLEY, KEVIN P.; HARRISON, RANE A.; MCCONNELL, RUSSELL E.; XU, KE
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 051097/0405 →
Assignment of Assignor's Interest
Mar 4, 2020
From: DOOLEY, KEVIN P.; HARRISON, RANE A.; MCCONNELL, RUSSELL E.; XU, KE
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 052008/0476 →
Assignment of Assignor's Interest
Jul 23, 2020
From: WILLIAMS, DOUGLAS E.; KULMAN, JOHN D.
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 053296/0547 →
Assignment of Assignor's Interest
Jul 23, 2020
From: PARK, KYONG-SU; BANDEIRA DE MELO, ELGA BERNARDO; LOTVALL, JAN
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 053296/0408 →
Assignment of Assignor's Interest
Aug 20, 2020
From: MCCONNELL, RUSSELL E.; DOOLEY, KEVIN P.; HARRISON, RANE A.; XU, KE
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 053554/0448 →
Assignment of Assignor's Interest
Nov 18, 2022
From: HOUDE, DAMIAN J.; CHOI, YOUNG JUN; KULMAN, JOHN D.; WILLIAMS, DOUGLAS E.
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 061823/0110 →
Assignment of Assignor's Interest
Aug 31, 2023
From: DOOLEY, KEVIN P.; HARRISON, RANE A.; MCCONNELL, RUSSELL E.; XU, KE
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 064790/0294 →
Assignment of Assignor's Interest
Aug 31, 2023
From: MCCONNELL, RUSSELL E.; DOOLEY, KEVIN P.; HARRISON, RANE A.; XU, KE
To: CODIAK BIOSCIENCES, INC.
Reel/Frame 064767/0063 →